Compounded tirzepatide: is it legal, safe, and worth it?

Tirzepatide tirzepatide by Eli Lilly

By the GLP Index editorial team Updated How we source

Compounded tirzepatide is not FDA-approved or FDA-reviewed. The tirzepatide shortage ended in 2024, so mass compounding is largely restricted. What that means, the safety questions, and how to vet a pharmacy.

What compounded tirzepatide is

Compounded tirzepatide is a custom-mixed version of the drug in Mounjaro and Zepbound, made by a compounding pharmacy — and it is not FDA-approved or reviewed for safety, effectiveness, or quality. It’s usually supplied in a multi-dose vial drawn with an insulin syringe, not in a fixed-dose brand pen.

Compounding legitimately exists to tailor a medication to an individual need. It is not a lawful route to a cheaper copy of a mass-market drug — the distinction at the center of this topic.

Most pages online still describe a “current shortage” that has, in fact, ended. Pharmacies could compound tirzepatide in volume largely because it was on the FDA drug shortage list. The FDA declared that shortage resolved — removing the main legal basis for mass compounding — and Eli Lilly has pursued sellers of compounded copies in court.

Is compounded tirzepatide safe?

The active ingredient carries the same GI-heavy side-effect profile as the brand — but with compounded product the real uncertainty is what’s in the vial: the dose, the purity, and how it was made.

How to spot a legitimate pharmacy

If you and your prescriber pursue compounded tirzepatide for a genuine clinical reason, these checks separate a licensed pharmacy from the grey market:

  • A prescription is required — “no prescription needed” means not legitimate.
  • State-licensed (503A) or FDA-registered (503B), verifiable via your state board of pharmacy or the FDA’s registered-facility list.
  • A licensed clinician evaluates you — not just a checkout form.
  • The product and its concentration are clearly labeled — not an unlabeled “research” vial.
  • No “research peptide,” “not for human use,” or bulk-powder language. That’s the clearest red flag.

Why is it still being sold?

Some pharmacies continue under patient-specific “personalized-dose” exceptions, and some sellers keep operating in the grey market despite the changed rules and Lilly’s lawsuits. None of that makes a product FDA-reviewed or a quoted price legitimate. We don’t sell or recommend any compounded seller — this page explains the landscape, it doesn’t route you to one.

Tirzepatide: the complete guide How it works, Mounjaro vs Zepbound, dosing, and how to get it legally

FAQ

Common questions about Tirzepatide compounded

Is compounded tirzepatide the same as Mounjaro or Zepbound?

It uses the same active ingredient, tirzepatide, but it's not the same product. Brand Mounjaro and Zepbound are FDA-approved and made to a verified dose and purity; compounded versions are mixed by a pharmacy and are not FDA-reviewed for dose, purity, effectiveness, or quality — which can vary between sellers.

Is compounded tirzepatide legal now that the shortage is over?

Largely no, for mass production. Compounding was permitted mainly because tirzepatide was on the FDA shortage list; the FDA declared that shortage resolved in late 2024. Compounding is now limited to narrow, patient-specific circumstances, and Eli Lilly has actively sued sellers of compounded copies. Re-verify current status before relying on it.

Is compounded tirzepatide safe?

It hasn't been FDA-reviewed for safety, and there's no clinical trial on compounded formulations. Reported risks include dosing errors and contamination. If you use it, use only a state-licensed pharmacy and a licensed prescriber — never a website selling "research peptides."

Does compounded tirzepatide work as well as the brand?

There's no evidence to say. The strong weight-loss numbers (like ~21%) come from trials of FDA-approved Mounjaro and Zepbound, not compounded versions, which can differ in dose and purity — so those results don't automatically transfer.

Why is compounded tirzepatide still being sold if the shortage ended?

Some pharmacies continue under "personalized-dose" or patient-specific exceptions, and some sellers keep operating in the grey market despite the changed rules and Lilly's lawsuits. A seller quoting you a price is not evidence the product is legal or FDA-reviewed.

Sources

Every claim on this page traces to primary literature or FDA labeling. Browse the full evidence library.

  1. FDA's concerns with unapproved GLP-1 drugs used for weight loss (U.S. Food & Drug Administration)
  2. FDA clarifies resolution of tirzepatide shortage (U.S. Food & Drug Administration)
This page is for informational purposes only and isn't medical advice. Talk to a licensed healthcare provider about your situation before starting, stopping, or changing any medication. See our medical disclaimer and editorial policy.

Written by the GLP Index editorial team · Updated July 16, 2026 · How we source

Keep exploring

Related guides & tools

Tirzepatide: the complete guideUses, how it works, and how to get it Read more Tirzepatide before and afterMore on Tirzepatide Read more GLP-1 safety informationBoxed warning & full safety details Read more